Ms. Muhlstock brings to the group not solely substantial expertise in managing mass torts, but in addition the total firepower of the Parker Waichman agency, lengthy concerned in multi-district litigation nationwide. Jerry Parker, the founding companion of the agency, commented that “Melanie Muhlstock is a gifted mass torts lawyer who has intensive expertise in pharmaceutical and medical machine litigation. The Plaintiffs’ Steering Committee within the Elmiron® MDL is getting certainly one of our greatest attorneys to the combat for Elmiron® victims.”
Ms. Muhlstock, who additionally at present serves as a member of the Plaintiffs’ Steering Committee and as Co-Chair of the Management Growth Committee (“LDC”) in In Re: Zantac (Ranitidine) Merchandise Legal responsibility Litigation (MDL NO. 2924), joins a singular group on this Plaintiffs’ Steering Committee, which is comprised of a number of of essentially the most completed girls within the subject of plaintiffs’ pharmaceutical litigation. “It’s an honor to be appointed by the Courtroom to work with this gifted group of legal professionals to hunt justice on behalf of these injured by their use of Elmiron®,” stated Ms. Muhlstock.
Though marketed as a remedy for interstitial cystitis, it’s alleged that early medical research of Elmiron®, relied upon to help approval of the drug, didn’t reveal that Elmiron® was an efficient remedy for interstitial cystitis within the first occasion. Certainly, the MDL includes quite a few lawsuits alleging that defendants Johnson & Johnson, Janssen Prescribed drugs and Ortho-McNeil Prescribed drugs, in addition to different firms concerned within the improvement, manufacture, and sale of the drug, didn’t warn, advise, educate or in any other case inform Elmiron® customers in addition to physicians and governmental regulators of affected person danger of impaired imaginative and prescient, retinal harm and maculopathy because of the usage of Elmiron®.
FOR MORE INFORMATION: Matt Bruck, Chief Working Officer (516) 723-4642
SOURCE Parker Waichman LLP